Glucose Ceramide Synthase Inhibitors Inhibit Osteoclast Activation Induced by Myeloma-Derived and De Novo Synthesized Glycosphingolipids by Xu, K, Antonopoulos, A, Spanoudakis, E, Parry, S, Chaidos, A, Hu, M, Butters, T, Dell, A, Rahemtulla, A, Horwood, N, Karadimitris, A

Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells. by Kotsianidis, I, Silk, J, Spanoudakis, E, Patterson, S, Almeida, A, Schmidt, R, Tsatalas, C, Bourikas, G, Cerundolo, V, Roberts, I, Karadimitris, A

Invariant NKT Cells Regulate Osteoclast Development and Function Under Homeostatic and during Conditions of Immune Activation by Hu, M, Basssett, J, Danks, L, Spanoudakis, E, Xu, K, Howell, P, Boyde, A, Horwood, N, Williams, G, Roberts, I, Karadimitris, A

Activated invariant NKT cells regulate osteoclast development and function by Hu, M, Bassett, JHD, Danks, L, Howell, PGT, Xu, K, Spanoudakis, E, Kotsianidis, I, Boyde, A, Williams, GR, Horwood, N, Roberts, I, Karadimitris, A

Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease by Ersek, A, Xu, K, Antonopoulos, A, Butters, TD, Santo, AE, Vattakuzhi, Y, Williams, LM, Goudevenou, K, Danks, L, Freidin, A, Spanoudakis, E, Parry, S, Papaioannou, M, Hatjiharissi, E, Chaidos, A, Alonzi, DS, Twigg, G, Hu, M, Dwek, RA, Haslam, S, Roberts, I, Dell, A, Rahemtulla, A, Horwood, NJ, Karadimitris, A